Table 2.
Changes in ERTOMDCRT, ERTHH, and ERTOMDRT and association with doses to the amygdala, lateral orbitofrontal cortex, and medial orbitofrontal cortex after adjusting for baseline scores.
| ERTOMDCRT | ERTTH | ERTOMDRT | ||||
|---|---|---|---|---|---|---|
| Beta | p-Value | Beta | p-Value | Beta | p-Value | |
| Amygdala | ||||||
| Right | 5.94 | 0.25 | −0.06 | 0.32 | 13.40 | 0.08 |
| Left | 7.34 | 0.07 | −0.07 | 0.19 | 13.12 | 0.03 |
| Highest mean RT dose | 7.20 | 0.05 | −0.05 | 0.27 | 12.56 | 0.02 |
| Lateral orbitofrontal cortex | ||||||
| Right | 5.55 | 0.17 | −0.07 | 0.14 | 14.30 | 0.02 |
| Left | 6.65 | 0.10 | −0.09 | 0.07 | 5.77 | 0.02 |
| Highest mean RT dose | 6.16 | 0.08 | −0.06 | 0.14 | 12.96 | 0.01 |
| Medial orbitofrontal cortex | ||||||
| Right | 7.73 | 0.09 | −0.10 | 0.08 | 18.58 | 0.01 |
| Left | 7.80 | 0.08 | −0.10 | 0.05 | 17.15 | 0.01 |
| Highest mean RT dose | 7.98 | 0.07 | −0.10 | 0.07 | 17.30 | 0.01 |